) Maruyama H, Shiina S: Antioxidant therapy 436Koroki K, Kanzaki H, Maeda T, Kobayashi K, Kiyono S, Nakamura M, Kondo T, Saito T, Motoyama T, Suzuki E, Nakamoto S, Tawada A, Chiba T, Arai M, Kanda T, Maruyama H, Kato J, Takemura R, Nozaki-Taguchi N, Shiroh I, Yokosuka O, Kato N: Propofol versus midazolam for sedation during radiofrequency ablation in patients with hepatocellular carci-noma. JGH Open, 2020; 5: 273-279.〈Reviews〉 1on ischemic hepatitis: Here we are and where do we go? Hepatol Int, 2020; 14: 456-459.) Shiina S, Gani RA, Yokosuka O, Maruyama H, Nagamatsu H, Payawal DA, Dokmeci AK, Lesmana LA, Tanwandee T, Lau G, Sarin SK, Omata M: APASL practical recommenda-tions for the management of hepatocellular carcinoma in the era of COVID-19. Hepatol Int, 2020: 1-10. 2
元のページ ../index.html#116